A 2024 Global Report on National Policies, Programmes, and Progress Towards Hepatitis C Elimination: Findings From 33 Hepatitis Elimination Profiles.

Details

• Alternative Title:
  The Lancet. Gastroenterology & Hepatology, 2025, v. 10, no. 7: A 2024 Global Report on National Policies, Programmes, and Progress Towards Hepatitis C Elimination: Findings From 33 Hepatitis Elimination Profiles.
• Journal Article:
  The Lancet. Gastroenterology & Hepatology
• Personal Author:
  Hiebert-Suwondo, Lindsey ; Manning, Jana ; Tohme, Rania A ; Buti, Maria ; Kondili, Loreta A ; Spearman, C Wendy ; Hajarizadeh, Behzad ; Turnier, Victoria ; Lazarus, Jeffrey V ; Grebely, Jason ; Dore, Gregory J ; Waked, Imam ; Ward, John W
• Corporate Authors:
  the National Hepatitis Elimination Profile Collaborators
• Description:
  The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, policy, and programme development for the elimination of viral hepatitis. To date, profiles from 33 countries and territories have been developed. These profiles reveal that 30 (91%) countries and territories have hepatitis C national action plans, 11 (33%) have systems to monitor hepatitis C-related mortality, 16 (48%) have systems to monitor hepatitis C incidence, and 18 (55%) have systems to track the number of people tested and treated. Some countries and territories continue to uphold barriers to hepatitis C treatment, with 12 (36%) still having partial or full restrictions on prescribing authority for non-specialists. Ten (30%) countries and territories have met the WHO 2025 diagnosis coverage target of 60%, five (15%) have met the treatment target of 50%, and seven (21%) have met the needle and syringe exchange target. Although there are examples of countries and territories across the income spectrum meeting these targets, policy development in low-income and middle-income countries and territories generally lags behind that in high-income countries and territories.
• Content Notes:
  Author manuscript
• Subjects:
  • Humans
  • Hepatitis C
  • Global Health
  • Disease Eradication
  • Health Policy
  • World Health Organization
  • Antiviral Agents
• Source:
  The Lancet. Gastroenterology & Hepatology, 2025, v. 10, no. 7
• DOI:
  https://doi.org/10.1016/S2468-1253(25)00068-8
• ISSN:
  2468-1253
• Pubmed ID:
  40409322
• Pubmed Central ID:
  PMC12308979
• Document Type:
  Text
• Funding:
  CC999999/ImCDC/Intramural CDC HHSUnited States/
• Genre:
  Journal Article
• Pages in Document:
  685-700 (33 pdf pages)
• Volume:
  10
• Issue:
  7
• Download URL:
  https://stacks.cdc.gov/view/cdc/261392/cdc_261392_DS1.pdf
• File Type:
  [PDF - 895.53 KB]
• Collection(s):
  CDC Public Access
• Main Document Checksum:
  urn:sha-512:868b7724b90ab951ae2a6fb5a43de1840c012e89694292c55244f528c6d7aae80aee00c4f181b92c0f114bcb025269cb6543ad09687685c73ca81bf28b9a09a9